NextFin News - The United States burned through nearly two-thirds of its Patriot interceptor stockpile and up to 80 percent of its THAAD inventory in seven weeks of war with Iran, and replacing them will take three to five years even with record production contracts now in hand - a shortfall that has left Washington with less leverage over Tehran and a widening window of vulnerability against China. Tom Karako, director of the Missile Defense Project at the Center for Strategic and International Studies, laid out the arithmetic in a public appearance this week: the Pentagon is spending exquisite interceptors faster than a peacetime industrial base can rebuild them, and the gap is now a constraint on strategy, not just a budget line.
The tension is stark. President Donald Trump has insisted the United States is not running short of weapons even as he requested additional funding for munitions, telling a recent gathering that "at the high end we have a lot, but we're preserving it." Yet the Pentagon has signed a $22.9 billion, seven-year Tomahawk contract with RTX's Raytheon, a $58.62 billion, seven-year PAC-3 Missile Segment Enhancement contract with Lockheed Martin, and is pushing a cheaper PAC-3 ACE interceptor into rapid development. The math problem is that contracts are not missiles, and a signature today does not put a round in a launcher for years.
The Arithmetic of Depletion
The war's cost in munitions is now quantifiable. A CSIS analysis published in April, after the ceasefire ended the 39-day air and missile campaign, estimated that U.S. forces expended at least 45 percent of their Precision Strike Missile stockpile, at least half of their THAAD interceptors, and nearly 50 percent of their Patriot air defense interceptors over roughly seven weeks of combat. The same analysis put Tomahawk losses at about 30 percent, Joint Air-to-Surface Standoff Missiles above 20 percent, and SM-3 and SM-6 ship-defense interceptors near 20 percent.
More recent CSIS estimates sharpen the picture. The United States entered the war with roughly 2,300 Patriot interceptors and 452 THAAD interceptors. It now has between 759 and 827 Patriots left - about a third of its pre-war inventory - and between 234 and 278 THAAD interceptors. At the upper bound, CSIS finds the United States could have burned through as many as 290 of an estimated 360 THAAD interceptors, more than 80 percent of the stockpile. Whether the drawdown is 50 percent or 80 percent, the replenishment timeline is the same, and it is measured in years, not months. Mark Cancian, a retired Marine Corps colonel and co-author of the CSIS work, put it plainly: "The high munitions expenditures have created a window of increased vulnerability in the western Pacific. It will take one to four years to replenish these inventories and several years after that to expand them to where they need to be."
That window is where the missile math bites hardest. The United States retains enough bombs and missiles to continue combat operations against Iran should the ceasefire collapse. What it no longer has, analysts conclude, is enough of the right weapons to fight a near-peer adversary at the same time - and the inventory will not return to pre-war levels on any timeline that matches the strategic clock in the Western Pacific.
Why Contracts Don't Equal Missiles
The Pentagon's answer has been to sign checks. RTX's Raytheon will accelerate Tomahawk production under a $22.9 billion, seven-year Navy contract announced in August, part of what the administration calls the Arsenal of Freedom. Lockheed Martin won a $58.62 billion, seven-year undefinitized contract action for PAC-3 MSE interceptors in July, following a $4.7 billion year-one award in April. The Army has asked for 133,000 additional GMLRS rockets by 2034. The fiscal 2026 budget proposals included $20.4 billion to boost munition stockpiles and improve the weapons supply chain.
But the transmission mechanism from contract to launcher is long and narrow. Raytheon's goal is to reach capacity for more than 1,000 Tomahawks a year; the pre-war procurement average over fiscal 2015 to 2026 was just 86 missiles a year, and the recent annual production rate was under 200. Existing orders will begin replacing the more than 1,000 Tomahawks expended during the war, but will not fully restore inventories to pre-war levels. Lockheed delivered 620 PAC-3 MSE interceptors in 2025, a 60 percent increase over two years, and has committed under a seven-year framework to lift annual capacity from roughly 600 to 2,000 by 2030. Army budget documents show a two- to three-year lag between contract award and delivery; contracts dating to 2023 call for 335 Precision Strike Missiles by 2029.
"The push for low-cost munitions is unlikely to have a material effect on the Iran War—at least not anytime soon," said Becca Wasser, defense lead at Bloomberg Economics. "Getting to a lower cost for exquisite munitions will take time. It requires developing new weapons or adapting old ones, which means going through new testing and evaluation processes."
The constraint is not money; it is the industrial base itself. Decades of peacetime procurement optimized defense firms for steady, predictable output - a single production line, a qualified supplier base, and just-in-time components - rather than surge capacity. Solid-rocket motors and propellants are cured in batches on fixed schedules, not assembled on a line that speeds up when the phone rings. Guidance seekers depend on a handful of qualified semiconductor and rare-earth suppliers. Skilled welders and composite technicians take months to train and clear. Test ranges and qualification slots are themselves bottlenecks, with finite windows to prove a lot before it ships. This is a structural problem: a production system built for efficiency, not depth, cannot be wished into a wartime tempo on a fiscal-year timeline.
There is also a demand-side distortion. The United States must replenish its own stocks, keep Ukraine supplied against Russian missile attacks, and meet the needs of 17 other countries that operate Patriot. Every interceptor built this year is already spoken for three ways over. That triage - prioritizing U.S. needs over allies, as delivery schedules were apparently re-sequenced in 2026 - is itself a signal that the shortfall is real and binding.
The Homeland Shield That Eats the Same Production Line
There is a second demand shock layered on top of the war, and it competes for the same industrial base. The administration's Golden Dome for America - a homeland missile-defense shield first pitched at $175 billion, with estimates since climbing toward $185 billion for the architecture alone and some independent assessments running into the half-trillion-dollar range - would require precisely the interceptors that are now in shortest supply. The fiscal 2026 budget reconciliation plan has already set aside $25 billion for early development.
The political logic is understandable: after watching Iranian missiles fly toward U.S. bases and allies, a domestic shield sells. The industrial logic is punishing. Golden Dome's interceptors - whether hit-to-kill exo-atmospheric vehicles, SM-3-class ship-based interceptors, or space-based sensors - draw from the same pool of solid-rocket motors, seekers, and integration lines that are already committed to the Arsenal of Freedom replenishment. A domestic shield does not add capacity; it adds a claimant. Every dollar and every production slot directed to Golden Dome is one that is not restoring the war-depleted stockpiles that underwrite deterrence in Europe and the Western Pacific.
This is the hidden cost of the missile math. The Pentagon is not choosing between replenishing yesterday's war and building tomorrow's shield. It is trying to do both with an industrial base sized for neither. The result is a queue in which the most urgent need - the inventory trough that defines the window of vulnerability - must wait behind the most visible political promise.
The Market Priced the War, Then Priced the Hangover
The defense sector's stock path tells the same story in a different currency. On March 2, the first trading day after the United States and Israel launched attacks on Iran, munitions makers rallied hard: Northrop Grumman closed up 6 percent, RTX up 4.7 percent, L3Harris up 3.8 percent, Lockheed Martin up 3.3 percent, and Boeing up 2 percent, with Lockheed, RTX, and Northrop hitting 52-week highs. The war was supposed to be the earnings catalyst investors had waited years for.
It did not hold. Months later, defense stocks have been surprisingly weak since the Iran war started, with Lockheed Martin and Northrop Grumman shares falling for a tenth straight session at one point in August. As of late August intraday trading, Lockheed Martin was near $563, down from a 52-week high of $692; RTX traded around $210, below its 52-week peak of $226.88; Northrop Grumman sat near $551. The iShares U.S. Aerospace & Defense ETF has returned about 29 percent over the past year - a solid figure that nonetheless understates how far the sector has fallen from its wartime highs. The sector as a whole now trades at a weighted-average price-to-earnings ratio near 34, a meaningful premium to the S&P 500's roughly 27.
The repricing is rational. A multi-billion-dollar backlog is not revenue, and revenue is not free cash flow when a company is simultaneously investing in new lines, hiring scarce labor, and absorbing inflation in components. The market initially bid defense stocks on the expectation of a short, sharp war followed by a replenishment boom. What investors are now pricing is a long, slow rebuild in which contract awards arrive faster than deliveries, and margins pay for the mobilization before shareholders do. Lockheed's Missiles and Fire Control segment grew sales 19 percent on PAC-3 and THAAD volume, and Northrop posted a record $35 billion Defense Systems backlog - evidence that the demand is real, and that converting it into earnings will take years.
The Counter-Thesis: Mobilization Is Already Underway
The strongest case against the structural-bottleneck reading is that America has done this before, and the Arsenal of Freedom is the real mobilization. The $22.9 billion Tomahawk deal and the $58.62 billion PAC-3 MSE framework give Raytheon and Lockheed the multi-year demand visibility that finally justifies capital expenditure. RTX already delivered three times more Tomahawks in the first half of 2026 than in the first half of 2025. Lockheed's PAC-3 ACE, introduced in July, is designed precisely to bypass the exquisite-munitions trap - a cheaper interceptor built on proven fire-control software that can be produced in volume with European partners. If the Pentagon buys it, the cost-per-kill falls and magazine depth returns faster than legacy production curves suggest.
Raytheon President Phil Jasper framed the moment as a genuine inflection: "We are making significant investments in our workforce, technology, supply chain and facilities to dramatically boost production capacity and meet surging demand." Tim Cahill, president of Lockheed Martin Missiles and Fire Control, said PAC-3 ACE "delivers exactly that by building on the unrivaled performance of the PAC-3 MSE" while giving allies a "budget-smart" option.
This case is not wrong on the direction - production is rising, and the contracts are real. It is wrong on the clock. Even an optimistic mobilization leaves the inventory trough in place through the remainder of this administration's term. The falsifying signal for the bottleneck thesis is specific: if RTX reports annualized Tomahawk output above 500 a year and Lockheed reports PAC-3 MSE output above 1,000 a year by fourth-quarter 2027 earnings, and the Pentagon confirms Patriot and THAAD inventories back above 70 percent of pre-war levels by mid-2028, then the structural constraint has been broken and the bear case on the rebuild fails. Until then, the backlog is a promise, not a stockpile.
What to Watch: The Replenishment Clock
The forward look splits cleanly by horizon. In the short term - through 2027 - the constraint binds. Expect continued triage between Ukraine, Indo-Pacific deterrence, and Middle East commitments, with re-sequenced deliveries and diplomatic friction as allies learn their orders have been pushed back. Defense stocks will likely trade on contract announcements rather than deliveries, with volatility around each earnings report's commentary on margins and capacity. The exposed are the primes' near-term free-cash-flow profiles and any ally counting on a delivery date inside this administration's term.
Over the medium term - 2028 to 2030 - the base case is gradual restoration. The Tomahawk ramp toward 1,000 a year and the PAC-3 MSE capacity expansion toward 2,000 a year should bring inventories back toward pre-war levels if contracts hold across administrations and no new conflict interrupts the pipeline. The upside case is that PAC-3 ACE and other low-cost interceptors are adopted quickly, compressing the cost curve and allowing the Pentagon to buy depth rather than just quality. The downside case is a renewed Iran conflict or a Western Pacific crisis that burns through the partially rebuilt stockpile before it recovers - the very window of vulnerability Cancian warned about.
Longer term, the structural question is whether the United States accepts a permanent shift in defense-industrial posture. A peacetime base cannot sustain a wartime inventory; the choice is either to keep a larger standing stockpile at higher cost, or to accept recurring windows of vulnerability between conflicts. The Arsenal of Freedom is an attempt to buy a third option - surge capacity on demand - but surge capacity that takes years to activate is not surge capacity in any meaningful sense.
The missile math is unforgiving. The United States can write $80 billion in contracts, but it cannot write missiles into existence. For the next several years, American leverage will be measured not by what the Pentagon has ordered, but by what is actually sitting in its launchers - and on that count, the arsenal is thinner than the rhetoric suggests.
Explore more exclusive insights at nextfin.ai.
